litlas
ログインアカウント作成

Michael Hallek

1992–2026 年に発表

321
論文数
59,750
被引用数
125
h 指数
313
i10 指数

被引用数

Michael Hallek の年別被引用数1976 年: 被引用 1 件1979 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 5 件1994 年: 被引用 19 件1995 年: 被引用 28 件1996 年: 被引用 33 件1997 年: 被引用 35 件1998 年: 被引用 31 件1999 年: 被引用 41 件2000 年: 被引用 65 件2001 年: 被引用 69 件2002 年: 被引用 113 件2003 年: 被引用 154 件2004 年: 被引用 115 件2005 年: 被引用 182 件2006 年: 被引用 147 件2007 年: 被引用 128 件2008 年: 被引用 250 件2009 年: 被引用 209 件2010 年: 被引用 230 件2011 年: 被引用 267 件2012 年: 被引用 334 件2013 年: 被引用 345 件2014 年: 被引用 417 件2015 年: 被引用 586 件2016 年: 被引用 510 件2017 年: 被引用 552 件2018 年: 被引用 613 件2019 年: 被引用 1,736 件2020 年: 被引用 2,146 件2021 年: 被引用 2,162 件2022 年: 被引用 1,662 件2023 年: 被引用 1,078 件2024 年: 被引用 1,922 件2025 年: 被引用 883 件2026 年: 被引用 42 件1977〜1978 年は被引用が無いため表示していません1980〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,745 件、この内訳の 24.4%ドイツ: 引用元論文 1,741 件、この内訳の 9%中国: 引用元論文 1,380 件、この内訳の 7.1%イギリス: 引用元論文 1,298 件、この内訳の 6.7%イタリア: 引用元論文 1,204 件、この内訳の 6.2%フランス: 引用元論文 943 件、この内訳の 4.8%スペイン: 引用元論文 678 件、この内訳の 3.5%オーストラリア: 引用元論文 580 件、この内訳の 3%オランダ: 引用元論文 577 件、この内訳の 3%スイス: 引用元論文 518 件、この内訳の 2.7%カナダ: 引用元論文 516 件、この内訳の 2.6%日本: 引用元論文 424 件、この内訳の 2.2%
0%24.4%その他 24.8%

機関

分野

  • Medicine62.8%
  • Biochemistry, Genetics and Molecular Biology26.8%
  • Immunology and Microbiology6.7%
  • Computer Science0.7%
  • Neuroscience0.6%
  • Engineering0.4%
  • その他2%

トピック

  • Chronic Lymphocytic Leukemia Research8.4%
  • Lymphoma Diagnosis and Treatment6.1%
  • Lung Cancer Research Studies2.8%
  • CAR-T cell therapy research2.5%
  • Virus-based gene therapy research2.3%
  • Immune Cell Function and Interaction2.2%
  • その他75.7%

共著者

全論文

検索で開く
  1. Comprehensive genomic profiles of small cell lung cancer

    著者: Julie George, Jing Lim, Se Jin Jang, Yupeng Cun, Luka Ozretić, Gu Kong, Frauke Leenders, Xin Lü, Lynnette Fernandez‐Cuesta, Graziella Bosco, Christian Müller, Ilona Dahmen, Nadine S. Jahchan, Kwon-Sik Park, Dian Yang, Anthony N. Karnezis, Dedeepya Vaka, Angela Torres, Maia Segura‐Wang, Jan O. Korbel, Roopika Menon, Sung‐Min Chun, Deokhoon Kim, Matt Wilkerson, Neil Hayes, David Engelmann, Brigitte M. Pützer, Marc Bos, Sebastian Michels, Ignacija Vlašić, Danila Seidel, Berit Pinther, Philipp Schaub, Christian Becker, Janine Altmüller, Jun Yokota, Takashi Kohno, Reika Iwakawa, Koji Tsuta, Masayuki Noguchi, Thomas Muley, Hans Hoffmann, Philipp A. Schnabel, Iver Petersen, Yuan Chen, Alex Soltermann, Verena Tischler, Chang‐Min Choi, Yong‐Hee Kim, Pierre P. Massion, Yong Zou, Dragana J. Jovanović, Milica Kontić, Gavin Wright, Prudence A. Russell, Benjamin Solomon, Ina Koch, Michael Lindner, Lucia Anna Muscarella, Annamaria la Torre, John K. Field, Marko Jakopović, Jelena Knežević, Esmeralda Castaños‐Vélez, Luca Roz, Ugo Pastorino, O.T. Brustugun, Marius Lund‐Iversen, Erik Thunnissen, Jens Köhler, Martin Schüler, Johan Botling, Martin Sandelin, Montse Sánchez‐Céspedes, Helga B. Salvesen, Viktor Achter, Ulrich Lang, Magdalena Bogus, Peter M. Schneider, Thomas Zander, Sascha Ansén, Michael Hallek, Jürgen Wolf, Martin Vingron, Yasushi Yatabe, William D. Travis, Peter Nürnberg, Christian Reinhardt, Sven Perner, Lukas C. Heukamp, Reinhard Büttner, Stefan A. Haas, Élisabeth Brambilla, Martin Peifer, Julien Sage, Roman K. Thomas - Nature 2015 被引用: 2,428

  2. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

    著者: Michael Hallek, Bruce D. Cheson, Daniel Catovsky, Federico Caligaris‐Cappio, Guillermo Dighiero, Hartmut Döhner, Peter Hillmen, Michael J. Keating, Emili Montserrat, Nicholas Chiorazzi, Stephan Stilgenbauer, Kanti R. Rai, John C. Byrd, Barbara Eichhorst, Susan O’Brien, Tadeusz Robak, John F. Seymour, Thomas J. Kipps - Blood 2018 被引用: 1,689

  3. Extracellular vesicle measurements with nanoparticle tracking analysis – An accuracy and repeatability comparison between NanoSight NS300 and ZetaView

    著者: Daniel Bachurski, Maximiliane Schuldner, Phuong‐Hien Nguyen, Alexandra Malz, Katrin S. Reiners, Patricia C. Grenzi, Felix Babatz, Astrid Schauß, Hinrich P. Hansen, Michael Hallek, Elke Pogge von Strandmann - Journal of Extracellular Vesicles 2019 被引用: 626

  4. First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

    著者: Barbara Eichhorst, Carsten Utoft Niemann, Arnon P. Kater, Moritz Fürstenau, Julia von Tresckow, Can Zhang, Sandra Robrecht, Michael Gregor, Gunnar Juliusson, Patrick Thornton, Philipp B. Staber, Tamar Tadmor, Vesa Lindström, Caspar da Cunha‐Bang, Christof Schneider, Christian Bjørn Poulsen, Thomas Illmer, Björn Schöttker, Thomas Nösslinger, Ann Janssens, Ilse Christiansen, Michaël Baumann, Henrik Frederiksen, Marjolein van der Klift, Ulrich Jäger, Maria B. L. Leys, Mels Hoogendoorn, Kourosh Lotfi, Holger Hebart, Tobias Gaska, Harry R. Koene, Lisbeth Enggaard, Jereon Goede, Josien C. Regelink, Anouk Widmer, Florian Simon, Nisha De Silva, Anna‐Maria Fink, Jasmin Bahlo, Kirsten Fischer, Clemens‐Martin Wendtner, Karl Anton Kreuzer, Matthias Ritgen, Monika Brüggemann, Eugen Tausch, Mark‐David Levin, Marinus van Oers, Christian H. Geisler, Stephan Stilgenbauer, Michael Hallek - New England Journal of Medicine 2023 被引用: 291

  5. Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

    著者: Kirsten Fischer, Othman Al‐Sawaf, Jasmin Bahlo, Anna‐Maria Fink, Maneesh Tandon, Mark Dixon, Sandra Robrecht, Simon Warburton, Kathryn Humphrey, Olga Samoylova, A. M. Liberati, Javier Pinilla‐Ibarz, Stephen Opat, Liliya Sivcheva, Katell Le Dû, Laura Fogliatto, Carsten Utoft Niemann, Robert Weinkove, Sue Robinson, Thomas J. Kipps, Sebastian Böettcher, Eugen Tausch, Rod Humerickhouse, Barbara Eichhorst, Clemens‐Martin Wendtner, Anton W. Langerak, Karl-Anton Kreuzer, Matthias Ritgen, Valentin Goede, Stephan Stilgenbauer, Mehrdad Mobasher, Michael Hallek - New England Journal of Medicine 2019 被引用: 852

  6. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    著者: Martin Peifer, Lynnette Fernandez‐Cuesta, Martin L. Sos, Julie George, Danila Seidel, Lawryn H. Kasper, Dennis Plenker, Frauke Leenders, Ruping Sun, Thomas Zander, Roopika Menon, Mirjam Koker, Ilona Dahmen, Christian Müller, Vincenzo Di Cerbo, Hans‐Ulrich Schildhaus, Janine Altmüller, Ingelore Baessmann, Christian Becker, Bram De Wilde, Jo Vandesompele, Diana Böhm, Sascha Ansén, Franziska Gabler, Ines Wilkening, Stefanie Heynck, Johannes M. Heuckmann, Xin Lü, Scott L. Carter, Kristian Cibulskis, Shantanu Banerji, Gad Getz, Kwon-Sik Park, Daniel Rauh, Christian Grütter, Matthias Fischer, Laura Pasqualucci, Gavin Wright, Zoe Wainer, Prudence A. Russell, Iver Petersen, Yuan Chen, Erich Stoelben, Corinna Ludwig, Philipp A. Schnabel, Hans Hoffmann, Thomas Muley, Michael Brockmann, Walburga Engel-Riedel, Lucia Anna Muscarella, Vito Michele Fazio, Harry J.M. Groen, Wim Timens, Hannie Sietsma, Erik Thunnissen, Egbert F. Smit, Daniëlle A.M. Heideman, Peter J.F. Snijders, Federico Cappuzzo, Claudia Ligorio, Stefania Damiani, John K. Field, Steinar Solberg, Odd Terje Brustugun, Marius Lund‐Iversen, Jörg Sänger, Joachim H. Clement, Alex Soltermann, Holger Moch, Walter Weder, Benjamin Solomon, Jean‐Charles Soria, Pierre Validire, Benjamin Besse, Élisabeth Brambilla, Christian Brambilla, Sylvie Lantuéjoul, Philippe Lorimier, Peter M. Schneider, Michael Hallek, William Pao, Matthew Meyerson, Julien Sage, Jay Shendure, Robert C. Schneider, Reinhard Büttner, Jürgen Wolf, Peter Nürnberg, Sven Perner, Lukas C. Heukamp, Paul K. Brindle, Stefan A. Haas, Roman K. Thomas - Nature Genetics 2012 被引用: 1,418

  7. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study

    著者: Max Augustin, Philipp Schommers, Melanie Stecher, Felix Dewald, Lutz Gieselmann, Henning Gruell, Carola Horn, Kanika Vanshylla, Veronica Di Cristanziano, Luise Osebold, Maria Roventa, Toqeer Riaz, Nikolai Tschernoster, Janine Altmueller, Léonard Rose, Susanne Salomon, Vanessa Priesner, Jan-Christoffer Lüers, Christian Albus, Stephan Rosenkranz, Birgit Gathof, Gerd Fätkenheuer, Michael Hallek, Florian Klein, Isabelle Suárez, Clara Lehmann - The Lancet Regional Health - Europe 2021 被引用: 747

  8. Mutations driving CLL and their evolution in progression and relapse

    著者: Dan A. Landau, Eugen Tausch, Amaro Taylor‐Weiner, Chip Stewart, Johannes G. Reiter, Jasmin Bahlo, Sandra Kluth, Ivana Božić, Mike Lawrence, Sebastian Böttcher, Scott L. Carter, Kristian Cibulskis, Daniel Mertens, Carrie Sougnez, Mara Rosenberg, Julian M. Hess, Jennifer Edelmann, Sabrina Kless, Michael Kneba, Matthias Ritgen, Anna Maria Fink, Kirsten Fischer, Stacey Gabriel, Eric S. Lander, Martin A. Nowak, Hartmut Döhner, Michael Hallek, Donna Neuberg, Gad Getz, Stephan Stilgenbauer, Catherine J. Wu - Nature 2015 被引用: 1,078

  9. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: B. Eichhorst, Robak, T, Montserrat, E, Ghia, P, Niemann, CU, Kater, AP, Gregor, M, Cymbalista, F, Buske, C, Hillmen, P, Michael Hallek, Mey, U - Annals of Oncology 2020 被引用: 568

  10. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures

    著者: Michael Hallek, Othman Al‐Sawaf - American Journal of Hematology 2021 被引用: 381

  11. Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

    著者: Richard R. Furman, Jeff P. Sharman, Steven Coutré, Bruce D. Cheson, John M. Pagel, Peter Hillmen, Jacqueline C. Barrientos, Andrew D. Zelenetz, Thomas J. Kipps, Ian W. Flinn, Paolo Ghia, Herbert Eradat, Thomas J. Ervin, Nicole Lamanna, Bertrand Coiffier, Andrew R. Pettitt, Shuo Ma, Stephan Stilgenbauer, Paula Cramer, Maria Aiello, Dave M. Johnson, Langdon L. Miller, Daniel Li, Thomas M. Jahn, Roger Dansey, Michael Hallek, Susan O’Brien - New England Journal of Medicine 2014 被引用: 1,684

  12. Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

    著者: Valentin Goede, Kirsten Fischer, Raymonde Busch, Anja Engelke, Barbara Eichhorst, Clemens‐Martin Wendtner, Tatiana Chagorova, Javier de la Serna, Marie‐Sarah Dilhuydy, Thomas Illmer, Stephen Opat, Carolyn Owen, Olga Samoylova, Karl‐Anton Kreuzer, Stephan Stilgenbauer, Hartmut Döhner, Anton W. Langerak, Matthias Ritgen, Michael Kneba, Elina Asikanius, Kathryn Humphrey, Michael Wenger, Michael Hallek - New England Journal of Medicine 2014 被引用: 1,500

  13. Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study

    著者: Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, Steven Coutré, John F. Seymour, Talha Munir, Soham D. Puvvada, Clemens‐Martin Wendtner, Andrew W. Roberts, Wojciech Jurczak, Stephen P. Mulligan, Sebastian Böttcher, Mehrdad Mobasher, Ming Zhu, Monali Desai, Brenda Chyla, Maria Verdugo, Sari H. Enschede, Elisa Cerri, Rod Humerickhouse, Gary Gordon, Michael Hallek, William G. Wierda - The Lancet Oncology 2016 被引用: 796

  14. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction

    著者: David M. Kurtz, Mohammad Shahrokh Esfahani, Florian Scherer, Joanne Soo, Michael C. Jin, Chih Long Liu, Aaron M. Newman, Ulrich Dührsen, Andreas Hüttmann, Olivier Casasnovas, Jason R. Westin, Matthais Ritgen, Sebastian Böttcher, Anton W. Langerak, Mark Roschewski, Wyndham H. Wilson, Gianluca Gaïdano, Davide Rossi, Jasmin Bahlo, Michael Hallek, Robert Tibshirani, Maximilian Diehn, Ash A. Alizadeh - Cell 2019 被引用: 239

  15. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

    著者: Michael Hallek, Bruce D. Cheson, Daniel Catovsky, Federico Caligaris‐Cappio, Guillaume Dighiero, Hartmut Döhner, Peter Hillmen, Michael J. Keating, Emili Montserrat, Kanti R. Rai, Thomas J. Kipps - Blood 2008 被引用: 3,193

  16. Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial

    著者: Othman Al‐Sawaf, Can Zhang, Maneesh Tandon, Arijit Sinha, Anna‐Maria Fink, Sandra Robrecht, Olga Samoylova, Anna Marina Liberati, Javier Pinilla‐Ibarz, Stephen Opat, Liliya Sivcheva, Katell Le Dû, Laura Fogliatto, Carsten Utoft Niemann, Robert Weinkove, Sue Robinson, Thomas J. Kipps, Eugen Tausch, William Schary, Matthias Ritgen, Clemens‐Martin Wendtner, Karl-Anton Kreuzer, Barbara Eichhorst, Stephan Stilgenbauer, Michael Hallek, Kirsten Fischer - The Lancet Oncology 2020 被引用: 327

  17. Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies

    著者: Daniel Thomalla, Laura Beckmann, Christina Grimm, Matteo Oliverio, Lydia Meder, Carmen Herling, Pascal Nieper, T. Feldmann, Olaf Merkel, Eva Lorsy, Alexandra da Palma Guerreiro, J. von Jan, Ilmars Kisis, Elena Wasserburger, Julia Claasen, E. Faitschuk-Meyer, Janine Altmüller, Peter Nürnberg, T.-P. Yang, Matthias Lienhard, Ralf Herwig, K.-A. Kreuzer, Christian P. Pallasch, Reinhard Büttner, Stephan Schäfer, John C. Hartley, Hinrich Abken, Martin Peifer, H. Kashkar, Gero Knittel, Barbara Eichhorst, Roland T. Ullrich, Marco Herling, Hans Christian Reinhardt, Michael Hallek, Michal R. Schweiger, Lukas P. Frenzel - Blood 2022 被引用: 131

  18. Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia

    著者: Othman Al‐Sawaf, Can Zhang, Hyun Yong Jin, Sandra Robrecht, Yoonha Choi, Sandhya Balasubramanian, Alex Kotak, Yi Meng Chang, Anna Maria Fink, Eugen Tausch, Christof Schneider, Matthias Ritgen, Karl‐Anton Kreuzer, Brenda Chyla, Joseph N. Paulson, Christian P. Pallasch, Lukas P. Frenzel, Martin Peifer, Barbara Eichhorst, Stephan Stilgenbauer, Yanwen Jiang, Michael Hallek, Kirsten Fischer - Nature Communications 2023 被引用: 93

  19. Molecular map of chronic lymphocytic leukemia and its impact on outcome

    著者: Binyamin A. Knisbacher, Ziao Lin, Cynthia K. Hahn, Ferran Nadeu, Martí Duran‐Ferrer, Kristen E. Stevenson, Eugen Tausch, Julio Delgado, Alex Barbera-Mourelle, Amaro Taylor‐Weiner, Pablo Bousquets‐Muñoz, Ander Díaz‐Navarro, Andrew Dunford, Shankara Anand, Helene Kretzmer, Jesús Gutiérrez‐Abril, Sara López-Tamargo, Stacey M. Fernandes, Clare Sun, Mariela Sivina, Laura Z. Rassenti, Christof Schneider, Shuqiang Li, Laxmi Parida, Alexander Meissner, François Aguet, Jan A. Burger, Adrian Wiestner, Thomas J. Kipps, Jennifer R. Brown, Michael Hallek, Chip Stewart, Donna Neuberg, José I. Martín‐Subero, Xosé S. Puente, Stephan Stilgenbauer, Catherine J. Wu, Elı́as Campo, Gad Getz - Nature Genetics 2022 被引用: 148

  20. Chronic lymphocytic leukaemia

    著者: Michael Hallek, Tait D. Shanafelt, Barbara Eichhorst - The Lancet 2018 被引用: 370

  21. Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial

    著者: Stephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, Peter Hillmen, John F. Seymour, Steven Coutré, Wojciech Jurczak, Stephen P. Mulligan, Anna Schuh, Sarit Assouline, Clemens‐Martin Wendtner, Andrew W. Roberts, Matthew S. Davids, Johannes Bloehdorn, Talha Munir, Sebastian Böttcher, Lang Zhou, Ahmed Hamed Salem, Monali Desai, Brenda Chyla, Jennifer A. Arzt, Su Young Kim, Maria Verdugo, Gary Gordon, Michael Hallek, William G. Wierda - Journal of Clinical Oncology 2018 被引用: 313

  22. Toll–Like Receptor 2–Mediated Innate Immune Response in Human Nonparenchymal Liver Cells Toward Adeno–Associated Viral Vectors

    著者: Marianna Hösel, Mathias Broxtermann, Hanna Janicki, Knud Esser, Silke Arzberger, Pia Hartmann, Sonja Gillen, Jörg Kleeff, Dirk Stabenow, Margarete Odenthal, Percy A. Knolle, Michael Hallek, Ulrike Protzer, Hildegard Büning - Hepatology 2011 被引用: 210

  23. Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study

    著者: Othman Al‐Sawaf, Can Zhang, Tong Lu, Michael Z. Liao, Anesh Panchal, Sandra Robrecht, Travers Ching, Maneesh Tandon, Anna‐Maria Fink, Eugen Tausch, Christof Schneider, Matthias Ritgen, Sebastian Böttcher, Karl‐Anton Kreuzer, Brenda Chyla, Dale Miles, Clemens‐Martin Wendtner, Barbara Eichhorst, Stephan Stilgenbauer, Yanwen Jiang, Michael Hallek, Kirsten Fischer - Journal of Clinical Oncology 2021 被引用: 142

  24. Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial

    著者: Kirsten Fischer, Jasmin Bahlo, Anna Maria Fink, Valentin Goede, Carmen Herling, Paula Cramer, Petra Langerbeins, Julia von Tresckow, Anja Engelke, Christian Maurer, Gábor Kovács, Marco Herling, Eugen Tausch, Karl-Anton Kreuzer, Barbara Eichhorst, Sebastian Böttcher, John F. Seymour, Paolo Ghia, Paula Marlton, Michael Kneba, Clemens‐Martin Wendtner, Hartmut Döhner, Stephan Stilgenbauer, Michael Hallek - Blood 2015 被引用: 700